Cannabis Use Disorder (CUD) is formally recognized in the DSM-5, requiring any 2 of 11 criteria in a 12-month period. About 9% of cannabis users develop it, rising to 17% for daily users. The most common symptoms: using more than intended, inability to cut back despite trying, craving, irritability and sleep problems when not using, and continued use despite problems with motivation, relationships, or mental health. Modern high-potency cannabis (20–30%+ THC) significantly increases dependence risk compared to prior decades.
The claim "weed isn't addictive" is one of the most persistent myths in addiction medicine, and one of the most harmful. Cannabis Use Disorder (CUD) is a formally recognized DSM-5 diagnosis, not a moral judgment or contested fringe theory. The science is settled: approximately 9% of people who use cannabis will develop dependence, and that figure rises to 17% for daily users.
What has changed is the product. Today's dispensary cannabis routinely tests at 20–30%+ THC, compared to roughly 4% in the 1980s. High-potency products produce stronger dopamine spikes, faster neuroadaptation, and more pronounced withdrawal, making the "I used to smoke fine, this is fine" comparison unreliable.
Loss of control (quantity): Using cannabis in larger amounts or over longer periods than intended
Unsuccessful control: Persistent desire or repeated unsuccessful efforts to cut down or control use
Time spent: A great deal of time spent obtaining, using, or recovering from cannabis
Craving: A strong desire or urge to use cannabis
Failure to fulfill obligations: Recurrent use resulting in failure to fulfill major role obligations at work, school, or home
Social/interpersonal problems: Continued use despite persistent social or interpersonal problems caused or worsened by it
Giving up activities: Important social, occupational, or recreational activities given up or reduced because of cannabis
Hazardous use: Recurrent use in situations where it is physically hazardous (driving, operating equipment)
Continued despite harm: Use continues despite knowing it causes or worsens a physical or psychological problem
Tolerance: Needing significantly more cannabis to achieve the same effect, or diminished effect with the same amount
Withdrawal: Characteristic cannabis withdrawal syndrome upon stopping, or using to avoid withdrawal symptoms
criteria met
criteria met
criteria met
Smoking or vaping within the first hour of waking up, a reliable indicator of dependence rather than recreational use.
Trying to take a break and returning to daily or near-daily use within days, despite genuine intention to stop.
Progressive loss of interest in goals, hobbies, exercise, or career that coincides with increased use.
Consistently prioritizing cannabis spending over other expenses, or feeling anxious when supply runs low.
The most commonly reported withdrawal symptom, disproportionate irritability, short temper, and mood swings when not using.
Heightened anxiety and restlessness between sessions, often what drove the next use, creating an anxiety-use cycle.
Insomnia and vivid, often disturbing dreams when stopping, THC suppresses REM sleep, which rebounds intensely upon cessation.
Loss of appetite and nausea in the first week of stopping, the reverse of cannabis's appetite-stimulating effect during use.
Needing to be high to feel relaxed, sociable, creative, or emotionally stable, cannabis has replaced baseline function.
Persistent thoughts about when you'll next smoke, whether you have enough, or how to get more, intrusive preoccupation.
Intense defensiveness when use is mentioned by loved ones, often disproportionate to the comment, reflecting denial.
Inability or strong reluctance to spend an evening, weekend, or vacation without using, reveals the scope of reliance.
Weed isn't addictive, it's just a habit.
Cannabis Use Disorder is a DSM-5 diagnosis. ~9% of users develop dependence, 17% of daily users. Cannabis withdrawal is a recognized medical syndrome since DSM-5 (2013).
You can't have physical withdrawal from weed.
Cannabis withdrawal produces real physical symptoms: insomnia, nausea, sweating, and physical discomfort, documented in controlled studies and recognized in DSM-5.
Modern cannabis is the same as what people smoked decades ago.
THC potency has increased from ~4% in the 1980s to 20–30%+ in today's products. Higher potency = stronger dopamine response = greater dependence risk.
If you're not using to get high, you don't have a problem.
Many people with CUD use primarily to feel "normal", to manage anxiety, sleep, or mood. Using to function rather than to get high is a marker of dependence, not evidence against it.
THC activates CB1 receptors in the brain's reward circuitry, triggering dopamine release in the nucleus accumbens, the same pathway activated by other addictive substances. With chronic use, the endocannabinoid system undergoes neuroadaptation: CB1 receptor density decreases (downregulation), and baseline endocannabinoid signaling, which normally regulates mood, appetite, and sleep, becomes blunted.
The result: without cannabis, the user experiences the deficits the drug was suppressing, anxiety, insomnia, irritability, poor appetite. These are not pre-existing conditions the person is "medicating." In many cases, they are withdrawal-driven states created by the use itself.
Days 1–3: Irritability, anxiety, craving, and sleep disruption begin. Appetite decreases.
Days 2–6: Peak withdrawal, symptoms most intense. Vivid dreams, night sweats, restlessness, mood instability.
Week 2: Physical symptoms resolve for most users. Psychological symptoms (anxiety, low mood) continue.
Weeks 2–4: Gradual normalization. Sleep improves but may not fully normalize for 30+ days in heavy users.
Month 1+: Some users experience extended low-grade anxiety or anhedonia for 1–3 months (PAWS, Post-Acute Withdrawal Syndrome). This is temporary and not a permanent state.
1-800-662-4357 · Free, confidential treatment referrals · 24/7 · samhsa.gov
marijuana-anonymous.org · 12-step peer support for cannabis use disorder
The most evidence-supported treatment for CUD. CBT addresses the thoughts, emotions, and behaviors that maintain use. Available through therapists, online platforms, and addiction treatment centers.
Brief, 2–4 session therapy that has demonstrated effectiveness for cannabis use disorder in clinical trials.
Track your weed-free streak, log cravings, and get daily AI coach check-ins · Free on iPhone
Yes, Cannabis Use Disorder is a DSM-5 diagnosis supported by decades of research. About 9% of cannabis users develop dependence (rising to 17% for daily users). Cannabis withdrawal is also a recognized medical syndrome included in DSM-5 since 2013.
Symptoms peak at days 2–6: irritability, anxiety, insomnia, vivid dreams, decreased appetite, restlessness, and depressed mood. Physical symptoms resolve within 2 weeks for most people, sleep problems may persist 30+ days in heavy users. Not medically dangerous, but psychologically difficult.
Key markers: you use more than you plan to, you've tried to stop and couldn't, you feel anxious or irritable when you haven't used for several hours, and you're using to feel "normal" rather than to get high. Any two DSM-5 criteria in 12 months qualifies as mild Cannabis Use Disorder.
Acute withdrawal resolves in 1–2 weeks. THC metabolites are detectable in urine for 3–30 days depending on use frequency and body composition. For heavy daily users, cognitive effects (memory, executive function) may not fully normalize for 28+ days after last use.
CBT (Cognitive Behavioral Therapy) has the strongest evidence base for CUD. Motivational Enhancement Therapy also shows effectiveness. No FDA-approved medications exist specifically for CUD, though some symptoms (anxiety, insomnia) may be addressed medically during withdrawal. SAMHSA (1-800-662-4357) provides free referrals.
Yes, a well-documented cycle. Short-term, THC reduces anxiety via CB1 receptor activation. Long-term, chronic use blunts the baseline endocannabinoid system, making baseline anxiety worse. When you're high, anxiety is reduced. When sober, anxiety is elevated above pre-use baseline. This creates a self-reinforcing use cycle where the drug is treating a problem it's causing.
Approximately 9% of people who use marijuana develop cannabis use disorder, lower than alcohol (15%) or tobacco (32%). However, if use begins in adolescence, the risk jumps to about 17%. Daily or near-daily adult users have roughly 25–50% risk of developing dependence.
People describe feeling unable to enjoy ordinary activities without cannabis, using more than intended despite repeated intentions to cut back, significant irritability and sleep disruption when not using, and organizing their day around getting high. Many don't recognize it as addiction because their use feels 'voluntary.'
Yes, Cannabis Withdrawal Syndrome is a formal DSM-5 diagnosis. Symptoms after stopping heavy daily use include: irritability, anxiety, sleep disturbances (vivid dreams), decreased appetite, restlessness, and depressed mood. Symptoms begin within 24–72 hours, peak around day 2–3, and largely resolve within 1–2 weeks.
Average THC concentration has increased from around 4% in the 1990s to 12–15%+ in commercial products today, concentrates can reach 80–90% THC. Higher potency produces stronger acute dopamine response, faster tolerance development, and likely higher addiction risk. Much of the existing research predates these high-potency products.
Heavy cannabis use, particularly high-THC products, is associated with increased risk of cannabis-induced psychosis and long-term elevation of schizophrenia risk, particularly in people with genetic vulnerability. The risk is substantially higher in adolescent users. Cannabis-induced psychotic episodes sometimes resolve with abstinence, others do not.
No FDA-approved medications exist specifically for cannabis use disorder. Behavioral treatments are most effective: Cognitive Behavioral Therapy (CBT), Motivational Enhancement Therapy (MET), and Contingency Management (rewarding abstinence). CBT plus MET shows the best evidence base. Brief intervention can work for mild-moderate cases.
Heavy cannabis use is associated with amotivational syndrome: reduced drive, difficulty initiating tasks, decreased goal-directed behavior, and emotional blunting. Research suggests most motivational deficits improve with sustained abstinence, but may take 4–8+ weeks to fully resolve after heavy long-term use.
Warning signs include: sudden drop in grades, loss of interest in previously valued activities, new peer group who all use cannabis, secrecy about whereabouts, mood swings when unable to use, neglecting hygiene or responsibilities, and possession of cannabis paraphernalia. Early intervention significantly improves outcomes.
The relationship is bidirectional. People with depression, anxiety, or PTSD often use cannabis for short-term symptom relief. However, cannabis use worsens long-term outcomes for these conditions, particularly anxiety and psychosis risk. Treating the underlying condition often reduces cannabis use.
THC is fat-soluble and stored in body fat, creating long detection windows. Typical windows in urine testing: occasional users 3–4 days, moderate users 5–7 days, daily users 10–15 days, heavy daily users potentially 30+ days. Urine tests detect THC metabolites (THC-COOH), not active THC.
Three main reasons: 1) Cannabis use becomes deeply conditioned to daily activities (eating, sleeping, socializing), requiring behavioral restructuring, 2) Post-acute withdrawal, especially sleep disruption and anhedonia, can persist for weeks, 3) Cultural narratives minimizing cannabis risks make it hard to take withdrawal seriously.
CBD itself is not considered addictive. It does not activate dopamine reward pathways the way THC does. The WHO has concluded CBD has no significant abuse potential. However, CBD products may contain trace THC, and users should distinguish CBD's profile from that of cannabis products containing significant THC.
The CAGE-AID (adapted for substances) asks: C, felt you should Cut down? A, people Annoyed by criticism of your use? G, Guilty about use? E, used marijuana as Eye-opener/first thing? Two or more 'yes' answers suggest problematic use warranting further assessment. The CUDIT-R is a cannabis-specific validated tool.
Acute withdrawal resolves in 1–2 weeks. Post-acute symptoms (irritability, poor sleep, cravings) can persist 4–8 weeks. Cognitive effects, particularly working memory and processing speed, improve over months of abstinence with significant recovery by 6 months. Most people in sustained abstinence report substantial functional improvement within 3 months.
Track your clean days, log cravings, and get daily AI coach support through withdrawal and beyond.
Download Forge Free →Also from Forge
Forge Desktop blocks porn and gambling sites on your computer, and tells one person you choose if you turn the blocker off. $7/month, separate from the app.
It won't help with what this article is about. It blocks websites. It can't block a shop, a bar, or a dealer. Mentioned here only because people ask, and because it's the same account.
Look at Forge DesktopFor what you're reading about here, the Forge iPhone app is the right tool, streak tracking, an AI coach, and an SOS mode for when a craving peaks.
Forge Desktop is a separate product from the Forge iPhone app, with its own subscription. Paying for one doesn't include the other. If you already have Forge Pro on your phone, that stays exactly as it is.